Inhibitor Therapeutics, Inc. — Cash Flow Charts
38 quarters of history · ending 2022-09-30 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow↑+51.9% +$48K
$-44K
Free Cash Flow↑+51.9% +$48K
$-44K
Financing Cash Flow
$80K
Dividends Paid
$0
Stock-Based Comp
$0
SBC Allocated Expense
$0